| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/17/2008 | CN101322720A Arsenic trioxide emulsion for intravenous injection and preparation thereof |
| 12/17/2008 | CN101322719A Arsenic trioxide solid lipid nano granule, formulation and preparation thereof |
| 12/17/2008 | CN101322712A Alprostadil nano granule formulation and preparation thereof |
| 12/17/2008 | CN101322711A Health care medicament for resisting fatigue and enhancing immunity and preparation thereof |
| 12/17/2008 | CN101322710A Levosimendan emulsion for intravenous injection and preparation thereof |
| 12/17/2008 | CN101322708A Extended release oral dosage composition |
| 12/17/2008 | CN101322699A Preparation of docetaxel liposome and freeze-dried powder injection thereof |
| 12/17/2008 | CN101322696A Soft capsules anti-leakage method |
| 12/17/2008 | CN101322692A Hydrochloric clindamycin nano granule formulation for injections and preparation thereof |
| 12/17/2008 | CN101322691A Naloxone hydrochloride nano granule powder injection formulation and preparation thereof |
| 12/17/2008 | CN101322690A Stable medicament lipid complexes |
| 12/17/2008 | CN101322689A Preparation of docetaxel long-circulating liposome and freeze-dried powder injection thereof |
| 12/17/2008 | CN101322686A Daimeton (sodium) suspension injection and preparation thereof |
| 12/17/2008 | CN101322683A Gel for eye containing bromfenac sodium hydrate and preparation thereof |
| 12/17/2008 | CN101322682A Preparation of indissoluble medicament nano granule |
| 12/17/2008 | CN101322681A Method for preparing nano micelle formulation of anthracene nucleus antineoplastic antibiotic |
| 12/17/2008 | CN100443547C Prepn process of nanometer particle of poly (amide-amine)-poly (L-benzyl-glutamate) |
| 12/17/2008 | CN100443499C High purity albumin production process |
| 12/17/2008 | CN100443120C Process for preparing water soluble cyclodextrin-C60 super molecule inclusion compound |
| 12/17/2008 | CN100443077C Composition comprising cysteamine for improving lactation in dairy animals |
| 12/16/2008 | US7465790 Therapeutic antibodies |
| 12/16/2008 | US7465774 Use of copolymers of carboxylic acids and long-chain compounds with isolated C-C multiple bonds as thickeners or dispersants |
| 12/16/2008 | US7465716 Targeted drug delivery with a hyaluronan ligand |
| 12/16/2008 | US7465449 Anti-αvβ6 antibodies |
| 12/16/2008 | US7465441 Using interleukins, immunoglobulin fusion; genetic engineering; signaling |
| 12/16/2008 | US7465440 Graft polymer of vinyl ester and polyether |
| 12/16/2008 | US7465437 Delivery of anti-migraine compounds through an inhalation route |
| 12/16/2008 | US7465436 Aerosol for delivery of benzotropine, pergolide, amantadine, deprenyl, or ropinerole, formed by vaporizing the drug that is coated on a solid support and condensing the vapor to form particles containing least 10 % by weight of the drug and less than 5 % by weight of degradation products |
| 12/16/2008 | US7465435 Delivery of beta-blockers through an inhalation route |
| 12/16/2008 | US7465293 Syringe for inducing therapeutically-effective proteins |
| 12/16/2008 | CA2407925C Biomaterials comprised of preadipocyte cells for soft tissue repair |
| 12/16/2008 | CA2395129C Process for producing nanometer particles by fluid bed spray-drying |
| 12/16/2008 | CA2369739C Compositions and methods for improving integrity of compromised body passageways and cavities |
| 12/16/2008 | CA2367020C Method for producing solid dosage forms containing cyclodextrin |
| 12/16/2008 | CA2276327C Adding pharmaceutically active compounds to substrates |
| 12/16/2008 | CA2133885C Crystalline inclusion complex of diclofenac with beta-cyclodextrin |
| 12/11/2008 | WO2008151257A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 12/11/2008 | WO2008151150A2 Peg-pei copolymers for nucleic acid delivery |
| 12/11/2008 | WO2008151019A1 Extended release of bioactive molecules from silicone hydrogels |
| 12/11/2008 | WO2008150974A1 Biodegradable flexible coating for implantable medical devices |
| 12/11/2008 | WO2008150505A1 Compounds, polymers and methods for treating gastrointestinal dysfunction |
| 12/11/2008 | WO2008150399A1 Resuscitation fluid |
| 12/11/2008 | WO2008150382A1 Delivery vehicles containing rosin resins |
| 12/11/2008 | WO2008150354A1 Method, composition and kit for treating degenerated disc disease and discogenic pain |
| 12/11/2008 | WO2008150261A1 Detection and quantitation of calicheamicin |
| 12/11/2008 | WO2008149894A1 Cellulose fine core particle, and method for production thereof |
| 12/11/2008 | WO2008149788A1 Solid dialysis preparation |
| 12/11/2008 | WO2008149668A1 Protein-containing composition |
| 12/11/2008 | WO2008149601A1 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
| 12/11/2008 | WO2008149440A1 Medicinal film preparation with rapidly dissolving property and flexibility |
| 12/11/2008 | WO2008149320A2 Slow release pharmaceutical composition made of microparticles |
| 12/11/2008 | WO2008149318A1 Natural honey-containing compositions and method of preparation |
| 12/11/2008 | WO2008149230A2 Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate |
| 12/11/2008 | WO2008149192A2 Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
| 12/11/2008 | WO2008148839A2 Long-acting polymeric prodrugs of exendin |
| 12/11/2008 | WO2008148734A1 Pharmaceutical formulation for the production of chewable tablets and lozenges |
| 12/11/2008 | WO2008148731A1 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 12/11/2008 | WO2008148515A1 Intranasal administration of asenapine and pharmaceutical compositions therefor |
| 12/11/2008 | WO2008148212A2 High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same |
| 12/11/2008 | WO2008148174A1 Wound repair composition and method |
| 12/11/2008 | WO2008125240A3 Method for producing storage-stable solutions from pelargonium extracts |
| 12/11/2008 | WO2008124522A3 Amylin formulations |
| 12/11/2008 | WO2008118370A3 Hyperbaric treatment in wound healing |
| 12/11/2008 | WO2008074108A3 Controlled release pharmaceutical composition of anti-hyperglycemic agent and its preparation |
| 12/11/2008 | WO2008070571A3 Vesicles of self-assembling block copolymers and methods for making and using the same |
| 12/11/2008 | WO2008069824A3 Compositions and methods for transport of molecules with enhanced release properties across biological barriers |
| 12/11/2008 | WO2008062481A3 Formulations of peg-interferon alpha conjugates |
| 12/11/2008 | WO2008055254A3 Formulations and methods for oral delivery of proteins |
| 12/11/2008 | WO2008051612A3 Light-mediated anti-cell proliferative compositions and methods |
| 12/11/2008 | WO2008021752A3 Method for increasing colostrum immunoglobulin level in animals |
| 12/11/2008 | WO2007138336A3 Treatment of pain by single chain, polypeptide fusion protein |
| 12/11/2008 | US20080306248 Conjugate of Biomacromolecule with Bioreductive and Preparative Method Thereof |
| 12/11/2008 | US20080306247 Antibody-containing solution formulations |
| 12/11/2008 | US20080306246 Process for Attaching Effector Molecules to Proteins |
| 12/11/2008 | US20080306212 Polymer conjugates of mutated neublastin |
| 12/11/2008 | US20080306104 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 12/11/2008 | US20080306075 Pharmaceutical Compositions For Transdermal Delivery |
| 12/11/2008 | US20080306039 Loteprednol Etabonate Aqueous Suspension |
| 12/11/2008 | US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 12/11/2008 | US20080305989 Peptides faciliatate non-invasive percutaneous or transdermal drug delivery of insulin, growth hormone, apomorphine, or PT-141 (peptide analogue of alpha -melanocyte-stimulating hormone) |
| 12/11/2008 | US20080305337 encapsulated magnetic nanoparticle central core of samarium-cobalt (SmCo5); endcapped with thiol-bound functional group-containing spacer groups; cancer-binding agent for magnetic resonance imaging; tissue-targeted therapy for detecting or treating cancer |
| 12/11/2008 | US20080305174 Polymeric nanocapsules for use in drug delivery |
| 12/11/2008 | US20080305172 Ophthalmic depot formulations for periocular or suconjunctival administration |
| 12/11/2008 | US20080305167 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080305164 Crystalline composition containing escitalopram |
| 12/11/2008 | US20080305150 Polymer Composition And Dosage Forms Comprising The Same |
| 12/11/2008 | US20080305149 Mucoadhesive vesicles for drug delivery |
| 12/11/2008 | US20080305140 Long-Term Delivery Formulations and Methods of Use Thereof |
| 12/11/2008 | US20080305139 Pharmaceutical Compositions Comprising Dextran with a Molecular Weight of 1.0-100 Kda and Processes for Their Preparation |
| 12/11/2008 | US20080305125 Mutant Forms Of EtxB and CtxB And Their Use As Carriers |
| 12/11/2008 | US20080305096 Method and composition for providing controlled delivery of biologically active substances |
| 12/11/2008 | US20080305074 Stem cell factor |
| 12/11/2008 | US20080305057 New and improved skin treatment systems |
| 12/11/2008 | US20080305048 Self-Assembling Nanoparticle Conjugates |
| 12/11/2008 | DE202007018618U1 G-CSF-Flüssigformulierung G-CSF liquid formulation |
| 12/11/2008 | DE102007026550A1 Extrudate mit verbesserter Geschmacksmaskierung Extrudates with improved taste masking |
| 12/11/2008 | DE102007026166A1 Thermoplastic shaping of polyvinyl alcohol for manufacturing granulates, foil, fibers or coating for use in pharmaceutical or cosmetic applications, involves accomplishing shaping in absence of extrusion additive |
| 12/11/2008 | DE102007026037A1 Gastroretentives System mit Alginat-Körper Gastroretentive system with alginate-body |
| 12/11/2008 | CA2724432A1 Compositions and methods for binding lysophosphatidic acid |